A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products.

The FDA has approved Rukobia, a first-in-class drug from ViiV Healthcare intended for older people with HIV, who have been on antiretroviral therapy (ART) for so long it is starting to fail.

London, 31 January 2025 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Commission has ...

The most iconic shades of red lipstick stand the test of time. The right red somehow always feel modern and fresh, even if it was invented decades ago. And the enthusiasm for some of these red lip ...

No. 15 overall pick in this year’s draft enjoys whirlwind first night as member of Red Wings organization Red Wings select ‘really good two-way player’ Michael Brandsegg-Nygard at No.

Just a few weeks ago on January 15, the Food and Drug Administration (FDA) under the Biden administration revoked authorization of the additive red dye 3, meaning it will be banned from foods and ...

Red Dye No. 3, or erythrosine, is a synthetic red food dye once popular in candies and cakes. The ... [+] FDA bans Red Dye No. 3 under the Delaney Clause, citing cancer risks observed in lab ...

Red eyes are caused when blood vessels in the sclera (white part of the eye) swell or burst. This may cause redness in part or all of the eye and result in other symptoms such as itchiness or blurred ...

Selection criteria for the awards emphasized innovative outreach initiatives that combined creative digital and traditional methods during fiscal year 2024, including activities for Red Ribbon Week.

After hours: January 31 at 4:40:34 PM EST Loading Chart for RBBN ...

(JTA) — One of the movies up for best picture at the 2024 Golden Globes awards is about the Holocaust. One of the most notable displays during the ceremony alludes to a current attack on Jews.